Want to see NVOS full AI Analyst Report?
| Aug 24 | Nov 23 | Feb 23 | Nov 21 | Aug 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 13.29M | $ 12.57M | $ 11.74M | $ 9.31M | $ 7.86M |
| Gross Profit | $ 5.74M | $ 4.95M | $ 4.80M | $ 3.82M | $ 3.06M |
| Operating Income | $ -8.31M | $ -8.55M | $ -9.59M | $ -4.27M | $ -4.26M |
| EBITDA | $ -10.08M | $ -5.85M | $ -22.48M | $ -2.58M | $ -2.78M |
| Net Income | $ -16.13M | $ -13.21M | $ -32.85M | $ -4.46M | $ -4.92M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 844.58K | $ 416.32K | $ 2.18M | $ 8.29M | $ 2.07M |
| Total Assets | $ 32.14M | $ 35.56M | $ 40.87M | $ 61.96M | $ 35.39M |
| Total Debt | $ 4.71M | $ 4.47M | $ 13.00M | $ 13.71M | $ 4.39M |
| Net Debt | $ 3.87M | $ 4.06M | $ 10.82M | $ 5.42M | $ 2.33M |
| Total Liabilities | $ 17.53M | $ 11.06M | $ 18.83M | $ 18.15M | $ 5.82M |
| Stockholders' Equity | $ 14.89M | $ 24.82M | $ 22.31M | $ 43.86M | $ 29.62M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.29M | $ -2.29M | $ -6.07M | $ -1.28M | $ -453.80K |
| Operating Cash Flow | $ -2.24M | $ -2.24M | $ -5.88M | $ -1.02M | $ -441.69K |
| Investing Cash Flow | $ -49.22K | $ -49.22K | $ 163.46K | $ 3.00M | $ 657.13K |
| Financing Cash Flow | $ 763.86K | $ 763.86K | $ -427.12K | $ 4.32M | $ -271.69K |
Novo Integrated Sciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.